Premium
‘Nurse: My back hurts!’: case study review of Degarelix in metastatic prostate cancer
Author(s) -
Turner Bruce,
DrudgeCoates Lawrence,
Pati Jhumur
Publication year - 2011
Publication title -
international journal of urological nursing
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.184
H-Index - 8
eISSN - 1749-771X
pISSN - 1749-7701
DOI - 10.1111/j.1749-771x.2011.01109.x
Subject(s) - medicine , prostate cancer , androgen deprivation therapy , hormone antagonist , disease , oncology , cancer , gynecology , hormone , urology , endocrine system
In the management of metastatic prostate cancer, treatment with androgen deprivation therapy, initially with surgery via bilateral orchidectomy and more recently with medical therapy using gonadotropin‐releasing hormone (GnRH) agonists, has remained the key treatment approaches for this disease stage. Notably, patients express a preference towards a medical therapy approach. We present the case study of a patient with symptomatic metastatic prostate cancer treated with the new GnRH antagonist degarelix.